XML 35 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
SEGMENT AND ENTERPRISE-WIDE INFORMATION
 12 Months Ended
Apr. 02, 2016
Segment Reporting [Abstract]  
SEGMENT AND ENTERPRISE-WIDE INFORMATION
SEGMENT AND ENTERPRISE-WIDE INFORMATION
We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Our operating segments are based primarily on geography. North America Plasma is a separate operating segment with dedicated segment management due the size and scale of the plasma business. We aggregate components within an operating segment that have similar economic characteristics.
In prior periods, the Company believed a single reportable segment was consistent with its basic organizational structure and believed aggregation was consistent with its primary basis for decision making. As a result, prior year segment information has been restated to conform to fiscal 2016's reportable segments.
The Company’s reportable segments are as follows:
•
Japan
•
Europe, Middle East and Africa (collectively “EMEA”)
•
North America Plasma
•
All Other
The Company has aggregated the following two operating segments into the All Other reportable segment based upon their similar operational and economic characteristics, including similarity of operating margin:
•
Americas Blood Center and Hospital
•
Asia - Pacific
Management measures and evaluates the Company’s operating segments based on operating margin. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and transformation costs, deal amortization, impairments and other (income)/expense associated with certain acquisitions. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Segment assets have not been presented since management does not evaluate the Company’s operating segments using this information. Further, management measures and evaluates the Company's net revenues and operating income on a constant currency basis, therefore segment information is presented on a constant currency basis.
Selected information by business segment is presented below:
(In thousands)
April 2,
2016
 
March 28,
2015
 
March 29,
2014
Net revenues
 
 
 
 
 
Japan
$
84,270

 
$
83,547

 
$
89,041

EMEA
175,874

 
183,753

 
193,691

North America Plasma
279,803

 
240,705

 
213,215

All Other
370,568

 
375,827

 
400,133

Net revenues (constant currency)
910,515

 
883,832

 
896,080

Effect of exchange rates
(1,683
)
 
26,541

 
42,429

Net revenues (reported)
$
908,832

 
$
910,373

 
$
938,509

(In thousands)
April 2,
2016
 
March 28,
2015
 
March 29,
2014
Segment operating income
 
 
 
 
 
Japan
$
37,165

 
$
36,843

 
$
38,685

EMEA
36,976

 
44,998

 
49,373

North America Plasma
100,367

 
89,092

 
82,497

All Other
135,580

 
142,531

 
154,099

Segment operating income (constant currency)
310,088

 
313,464

 
324,654

Corporate operating expenses (constant currency)
(194,361
)
 
(189,867
)
 
(186,562
)
Non-GAAP operating income (constant currency)
115,727

 
123,597

 
138,092

Effect of exchange rates
3,977

 
13,906

 
21,147

Non-GAAP operating income (reported)
119,704

 
137,503

 
159,239

Unallocated amounts
 
 
 
 
 
Restructuring and transformation costs
42,185

 
69,697

 
84,706

Deal amortization
28,958

 
30,184

 
28,056

Impairment of assets
97,230

 
—

 
—

Contingent consideration (income) expense
(4,727
)
 
(2,918
)
 
45

Operating (loss) income
$
(43,942
)
 
$
40,540

 
$
46,432

(In thousands)
April 2,
2016
 
March 28,
2015
 
March 29,
2014
Depreciation and amortization
 
 
 
 
 
Japan
$
774

 
$
767

 
$
839

EMEA
5,146

 
5,045

 
4,695

North America Plasma
12,944

 
11,229

 
8,776

All Other
71,047

 
69,012

 
67,430

Total depreciation and amortization (excluding impairment charges)
$
89,911

 
$
86,053

 
$
81,740

(In thousands)
April 2,
2016
 
March 28,
2015
 
March 29,
2014
Long-lived assets(1)
 
 
 
 
 
Japan
$
33,159

 
$
31,810

 
$
28,544

EMEA
63,861

 
66,223

 
59,034

North America Plasma
116,001

 
101,272

 
75,597

All Other
124,613

 
122,643

 
108,262

Total long-lived assets
$
337,634

 
$
321,948

 
$
271,437

(1)Long-lived assets are comprised of property, plant and equipment.
Long-lived assets in our principle operating regions are as follows:
 
April 2,
2016
 
March 28,
2015
 
March 29,
2014
United States
$
231,744

 
$
208,439

 
$
185,227

Japan
2,022

 
1,618

 
2,563

Europe
18,672

 
27,786

 
37,154

Asia
40,235

 
39,032

 
8,785

Other
44,961

 
45,073

 
37,708

Total
$
337,634

 
$
321,948

 
$
271,437


Net revenues by product line are as follows:
(In thousands)
April 2,
2016
 
March 28,
2015
 
March 29,
2014
Disposable revenues
 

 
 

 
 

Plasma disposables
$
348,785

 
$
319,190

 
$
291,895

Blood center disposables
 

 
 

 
 

Platelet
143,274

 
152,588

 
156,643

Red cell
39,256

 
42,700

 
42,378

Whole blood
128,532

 
143,905

 
190,698

 
311,062

 
339,193

 
389,719

Hospital disposables
 

 
 

 
 

Diagnostics
50,882

 
42,187

 
33,302

Surgical
59,902

 
62,540

 
66,876

OrthoPAT
13,823

 
20,316

 
25,042

 
124,607

 
125,043

 
125,220

 
 
 
 
 
 
Disposables revenue
784,454

 
783,426

 
806,834

 
 
 
 
 
 
Software solutions
72,434

 
72,185

 
70,441

Equipment & other
51,944

 
54,762

 
61,234

Net revenues
$
908,832

 
$
910,373

 
$
938,509


Net revenues generated in our principle operating regions are as follows:
 
April 2,
2016
 
March 28,
2015
 
March 29,
2014
United States
$
519,440

 
$
494,788

 
$
500,719

Japan
81,411

 
88,298

 
108,679

Europe
187,725

 
215,575

 
224,792

Asia
111,758

 
102,095

 
94,762

Other
8,498

 
9,617

 
9,557

Total
$
908,832

 
$
910,373

 
$
938,509